Table 14. Recommendations for ventricular strain analysis in acquired heart diseases of childhood20,51,105–128 .
| Indication | Recommendation class | Evidence level |
|---|---|---|
| Cardiotoxicity in pediatric oncology | IIa | B |
| Autoimmune and viral myocarditis | IIa | B |
| Dilated cardiomyopathy: selection for resynchronization therapy | IIa | B |
| Vascular graft disease after heart transplantation | IIb | B |
| Rejection after heart transplantation | IIb | B |
| Muscular dystrophies (e.g. Duchenne) | IIa | B |
| Storage diseases (e.g. Pompe and MPS) | IIa | B |
| Kawasaki disease | IIa | C |
| Sepsis | IIb | B |
| Chronic renal failure | IIb | B |
| HIV/AIDS infection | IIa | B |
| Chronic anemias (e.g. thalassemia) | IIa | B |
| Pulmonary hypertension | IIa | B |
AIDS: acquired immunodeficiency syndrome; HIV: human immunodeficiency virus; MPS: mucopolysaccharidoses.